Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations (Q46674846)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations |
scientific article published in January 2005 |
Statements
1 reference
Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations (English)
1 reference
1 reference
1 reference
Carlos Fontes-Ribeiro
1 reference
Teresa Nunes
1 reference
Carla Neta
1 reference
Ricardo Lima
1 reference
Susana Tavares
1 reference
Tice Macedo
1 reference
1 January 2005
1 reference
1 reference
6
1 reference
5
1 reference
253-260
1 reference